Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity

Joanna J. Messmann, Tanja Reisser, Frank Leithäuser, Manfred B. Lutz, Klaus-Michael Debatin, Gudrun Strauss

Blood (2015) 126 (9): 1138–1148.

https://doi.org/10.1182/blood-2015-01-624163

Published: 2015

Includes: Supplemental data

Journal Articles

Recombinant CD95-Fc (APG101) prevents graft-versus-host disease in mice without disabling antitumor cytotoxicity and T-cell functions

Natalie Hartmann, Joanna J. Messmann, Frank Leithäuser, Maxi Weiswange, Michael Kluge, Harald Fricke, Klaus-Michael Debatin, Gudrun Strauss

Blood (2013) 121 (3): 556–565.

https://doi.org/10.1182/blood-2012-04-423392

Published: 2013

Includes: Supplemental data

Journal Articles

APG101 - a Novel Inhibitor of CD95/CD95L Signaling Prevents Graft-Versus-Host Disease without Disabling T Cell Effector Function and Anti-Tumor Activity,

Gudrun Strauss, PhD, Natalie Hartmann, PhD, Michael Kluge, PhD, Harald Fricke, MD, PhD, Klaus-Michael Debatin, MD, PhD

Blood (2011) 118 (21): 4019.

https://doi.org/10.1182/blood.V118.21.4019.4019

Published: 2011

Journal Articles

Activation of Acute Lymphocytic Leukemia Blasts with CpG ODN, IL-4 and CD40 Ligand Facilitates Enhanced Anti-Leukemic CTL Responses

Dorit Fabricius, Lucia Breckerbohm, Manon Queudeville, MD, Angelika Vollmer, Sarah M. Eckhoff, MD, Johanna Pfeil, Gudrun Strauss, PhD, Simone Fulda, MD, Bernd Jahrsdoerfer, MD, Lueder H Meyer, MD, Klaus-Michael Debatin, MD

Blood (2010) 116 (21): 3907.

https://doi.org/10.1182/blood.V116.21.3907.3907

Published: 2010

Journal Articles

Effective Depletion of Alloreactive T Cells by CD95l-Transduced Cells with Preservation of FoxP3 Regulatory T-Cells.

Eva-Maria Jacobsen, Till Wenger, Ingrid Herr, PhD, Gudrun Strauss, PhD, Klaus-Michael Debatin, MD, Wilhelm Friedrich, MD, Susanna M. Muller, MD

Blood (2005) 106 (11): 1258.

https://doi.org/10.1182/blood.V106.11.1258.1258

Published: 2005

Journal Articles

Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

Karsten Stahnke, Simone Fulda, Claudia Friesen, Gudrun Strauß, Klaus-Michael Debatin

Blood (2001) 98 (10): 3066–3073.

https://doi.org/10.1182/blood.V98.10.3066

Published: 2001

Journal Articles

Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells

Simone Fulda, Gudrun Strauss, Eric Meyer, Klaus-Michael Debatin

Blood (2000) 95 (1): 301–308.

https://doi.org/10.1182/blood.V95.1.301

Published: 2000

NARROW

In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity

Recombinant CD95-Fc (APG101) prevents graft-versus-host disease in mice without disabling antitumor cytotoxicity and T-cell functions

APG101 - a Novel Inhibitor of CD95/CD95L Signaling Prevents Graft-Versus-Host Disease without Disabling T Cell Effector Function and Anti-Tumor Activity,

Activation of Acute Lymphocytic Leukemia Blasts with CpG ODN, IL-4 and CD40 Ligand Facilitates Enhanced Anti-Leukemic CTL Responses

Effective Depletion of Alloreactive T Cells by CD95l-Transduced Cells with Preservation of FoxP3 Regulatory T-Cells.

Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells

Email alerts

ASH Publications

American Society of Hematology

In vitro-generated MDSCs prevent murine GVHD by inducing type 2 T cells without disabling antitumor cytotoxicity

Recombinant CD95-Fc (APG101) prevents graft-versus-host disease in mice without disabling antitumor cytotoxicity and T-cell functions

APG101 - a Novel Inhibitor of CD95/CD95L Signaling Prevents Graft-Versus-Host Disease without Disabling T Cell Effector Function and Anti-Tumor Activity,

Activation of Acute Lymphocytic Leukemia Blasts with CpG ODN, IL-4 and CD40 Ligand Facilitates Enhanced Anti-Leukemic CTL Responses

Effective Depletion of Alloreactive T Cells by CD95l-Transduced Cells with Preservation of FoxP3 Regulatory T-Cells.

Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy

Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only